Crescent Capital BDC, Inc. CCAP
Nasdaq · XNAS · stock · website · IPO 2020-02-03
Chart by TradingView
4/9
Piotroski F — financial health
—
Altman Z″ — distress risk
196.5%
Dividend payout · at-risk
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$98.7M | -$106.8M | -$100.3M | -$56.8M | -$44.1M |
| Net income | $34.5M | $73.6M | $83.8M | $15.5M | $83.6M |
| Operating cash flow | $74.7M | $58.9M | $92.3M | $28.0M | -$157.7M |
| Total assets | $1.6B | $1.7B | $1.6B | $1.3B | $1.3B |
| Total liabilities | $916.1M | $915.6M | $884.8M | $690.3M | $665.5M |
| Shareholders' equity | $706.0M | $740.6M | $742.6M | $612.5M | $652.3M |
| Ratios | |||||
| Return on assets | 2.1% | 4.4% | 5.2% | 1.2% | 6.3% |
| Return on equity | 4.9% | 9.9% | 11.3% | 2.5% | 12.8% |
| Debt / equity | 1.24× | 1.18× | 1.14× | 1.07× | 0.97× |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0001633336 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.